165 related articles for article (PubMed ID: 23628646)
1. Putative drug and vaccine target protein identification using comparative genomic analysis of KEGG annotated metabolic pathways of Mycoplasma hyopneumoniae.
Damte D; Suh JW; Lee SJ; Yohannes SB; Hossain MA; Park SC
Genomics; 2013 Jul; 102(1):47-56. PubMed ID: 23628646
[TBL] [Abstract][Full Text] [Related]
2. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets.
Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y
Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study.
Chawley P; Samal HB; Prava J; Suar M; Mahapatra RK
Genomics; 2014 Jan; 103(1):83-93. PubMed ID: 24368230
[TBL] [Abstract][Full Text] [Related]
4. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
5.
Birhanu BT; Lee SJ; Park NH; Song JB; Park SC
J Vet Sci; 2018 Mar; 19(2):188-199. PubMed ID: 29032659
[No Abstract] [Full Text] [Related]
6. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K
Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomics study for the identification of drug and vaccine targets in Staphylococcus aureus: MurA ligase enzyme as a proposed candidate.
Ghosh S; Prava J; Samal HB; Suar M; Mahapatra RK
J Microbiol Methods; 2014 Jun; 101():1-8. PubMed ID: 24685600
[TBL] [Abstract][Full Text] [Related]
8. In silico identification of putative drug targets from different metabolic pathways of Aeromonas hydrophila.
Sharma V; Gupta P; Dixit A
In Silico Biol; 2008; 8(3-4):331-8. PubMed ID: 19032165
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.
Samal HB; Prava J; Suar M; Mahapatra RK
J Theor Biol; 2015 Mar; 369():67-79. PubMed ID: 25637765
[TBL] [Abstract][Full Text] [Related]
10. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli.
Simionatto S; Marchioro SB; Galli V; Hartwig DD; Carlessi RM; Munari FM; Laurino JP; Conceição FR; Dellagostin OA
Protein Expr Purif; 2010 Feb; 69(2):132-6. PubMed ID: 19747547
[TBL] [Abstract][Full Text] [Related]
11. Proteomic survey of the pathogenic Mycoplasma hyopneumoniae strain 7448 and identification of novel post-translationally modified and antigenic proteins.
Pinto PM; Chemale G; de Castro LA; Costa AP; Kich JD; Vainstein MH; Zaha A; Ferreira HB
Vet Microbiol; 2007 Mar; 121(1-2):83-93. PubMed ID: 17182197
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232.
Pendarvis K; Padula MP; Tacchi JL; Petersen AC; Djordjevic SP; Burgess SC; Minion FC
BMC Genomics; 2014 Jul; 15(1):576. PubMed ID: 25005615
[TBL] [Abstract][Full Text] [Related]
13. Survey of surface proteins from the pathogenic Mycoplasma hyopneumoniae strain 7448 using a biotin cell surface labeling approach.
Reolon LA; Martello CL; Schrank IS; Ferreira HB
PLoS One; 2014; 9(11):e112596. PubMed ID: 25386928
[TBL] [Abstract][Full Text] [Related]
14. The genome sequence of Mycoplasma hyopneumoniae strain 232, the agent of swine mycoplasmosis.
Minion FC; Lefkowitz EJ; Madsen ML; Cleary BJ; Swartzell SM; Mahairas GG
J Bacteriol; 2004 Nov; 186(21):7123-33. PubMed ID: 15489423
[TBL] [Abstract][Full Text] [Related]
15. Structure-based functional inference of hypothetical proteins from Mycoplasma hyopneumoniae.
da Fonsêca MM; Zaha A; Caffarena ER; Vasconcelos AT
J Mol Model; 2012 May; 18(5):1917-25. PubMed ID: 21870198
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae.
Barh D; Kumar A
In Silico Biol; 2009; 9(4):225-31. PubMed ID: 20109152
[TBL] [Abstract][Full Text] [Related]
17. Novel Drug Targets for Food-Borne Pathogen Campylobacter jejuni: An Integrated Subtractive Genomics and Comparative Metabolic Pathway Study.
Mehla K; Ramana J
OMICS; 2015 Jul; 19(7):393-406. PubMed ID: 26061459
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential drug targets by subtractive genome analysis of Bacillus anthracis A0248: An in silico approach.
Rahman A; Noore S; Hasan A; Ullah R; Rahman H; Hossain A; Ali Y; Islam S
Comput Biol Chem; 2014 Oct; 52():66-72. PubMed ID: 25254941
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential drug targets by subtractive genome analysis of Escherichia coli O157:H7: an in silico approach.
Mondal SI; Ferdous S; Jewel NA; Akter A; Mahmud Z; Islam MM; Afrin T; Karim N
Adv Appl Bioinform Chem; 2015; 8():49-63. PubMed ID: 26677339
[TBL] [Abstract][Full Text] [Related]
20. Variable number of tandem aminoacid repeats in adhesion-related CDS products in Mycoplasma hyopneumoniae strains.
de Castro LA; Rodrigues Pedroso T; Kuchiishi SS; Ramenzoni M; Kich JD; Zaha A; Henning Vainstein M; Bunselmeyer Ferreira H
Vet Microbiol; 2006 Sep; 116(4):258-69. PubMed ID: 16730926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
